Cancer incidence among Japanese atomic-bomb survivors
- Radiation Effects Research Foundation, Hiroshima (Japan)
- National Cancer Institute, Bethesda, MD (United States)
The long-term follow-up of the Life Span Study (LSS) cohort of atomic bomb survivors is a major source of epidemiological data for risk assessment used in radiological protection. Previous analyses of cancer risk have primarily focused on mortality data for this cohort. Recently, it has also become possible to use cancer incidence data from the tumor registries in Hiroshima and Nagasaki for a subset of the LSS cohort, and a series of reports from the first comprehensive analyses of the LSS cancer incidence data have been published. The availability of cancer incidence data has also prompted a series of in-depth studies of specific cancers. This paper describes how the incidence and mortality data differ and discusses how the incidence data will add a new dimension to the radiation risk assessment.
- Research Organization:
- National Council on Radiation Protection and Measurements, Bethesda, MD (United States)
- OSTI ID:
- 526017
- Report Number(s):
- CONF-960405-; TRN: 98:008243
- Resource Relation:
- Conference: 32. annual meeting of the National Council on Radiation Protection and Measurements, Arlington, VA (United States), 3-4 Apr 1996; Other Information: PBD: 1 Mar 1997; Related Information: Is Part Of Implications of new data on radiation cancer risk. Proceedings No. 18; Boice, J.D. Jr. [ed.]; PB: 320 p.
- Country of Publication:
- United States
- Language:
- English
Similar Records
Cancer incidence in atomic bomb survivors. Part IV: Comparison of cancer incidence and mortality
Comparison of All Solid Cancer Mortality and Incidence Dose-Response in the Life Span Study of Atomic Bomb Survivors, 1958–2009